Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs DOI Creative Commons
Natalia Molchanova, Per Brinch Hansen, Henrik Franzyk

и другие.

Molecules, Год журнала: 2017, Номер 22(9), С. 1430 - 1430

Опубликована: Авг. 29, 2017

The rapid emergence of multidrug-resistant pathogens has evolved into a global health problem as current treatment options are failing for infections caused by pan-resistant bacteria. Hence, novel antibiotics in high demand, and this reason antimicrobial peptides (AMPs) have attracted considerable interest, since they often show broad-spectrum activity, fast killing cell selectivity. However, the therapeutic potential natural AMPs is limited their short plasma half-life. Antimicrobial peptidomimetics mimic structure biological activity AMPs, but display extended stability presence matrices. In present review, focus on developments reported last decade with respect to design, synthesis, cytotoxic side effects well applications anti-infective agents. Specifically, only modular residues connected via amide linkages will be discussed. These comprise classes α-peptoids (N-alkylated glycine oligomers), β-peptoids β-alanine β3-peptides, α/β3-peptides, α-peptide/β-peptoid hybrids, α/γ N-acylated N-aminoethylpeptides (AApeptides), oligoacyllysines (OAKs). Such particular interest due potent versatile convenient optimization assembly standard solid-phase procedures.

Язык: Английский

Graphene oxide and carbon dots as broad-spectrum antimicrobial agents – a minireview DOI
Anisha Anand, Binesh Unnikrishnan, Shih‐Chun Wei

и другие.

Nanoscale Horizons, Год журнала: 2018, Номер 4(1), С. 117 - 137

Опубликована: Сен. 5, 2018

Complex antibacterial mechanisms of graphene oxide and carbon dots.

Язык: Английский

Процитировано

274

Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies DOI Creative Commons
Francisca Alcayaga‐Miranda, Jimena Cuenca, Maroun Khoury

и другие.

Frontiers in Immunology, Год журнала: 2017, Номер 8

Опубликована: Март 30, 2017

While mesenchymal stem cells (MSCs)-based therapy appears to be promising, there are concerns regarding possible side effects related the unwanted suppression of antimicrobial immunity leading an increased risk infection. Conversely, recent data show that MSCs exert strong through indirect and direct mechanisms, partially mediated by secretion peptides proteins (AMPs). In fact, have been reported increase bacterial clearance in pre-clinical models sepsis, acute respiratory distress syndrome cystic fibrosis infections. This article reviews current evidence effector function MSCs, focusing mainly on role MSCs-derived AMPs. The strategies might modulate expression these AMPs, enhanced effect highlighted. Furthermore, studies evaluating presence AMPs cargo extracellular vesicles (EVs) underlined as perspective opportunities develop new drug delivery tools. potential EVs can also heightened cell conditioning and/or loading. Finally, improving pharmacokinetics delivery, addition deciphering multi-target status should synergistically lead key advances against infections caused resistant strains.

Язык: Английский

Процитировано

253

The Vast Structural Diversity of Antimicrobial Peptides DOI
Johannes Koehbach, David J. Craik

Trends in Pharmacological Sciences, Год журнала: 2019, Номер 40(7), С. 517 - 528

Опубликована: Июнь 20, 2019

Язык: Английский

Процитировано

237

Antimicrobial peptides: new hope in the war against multidrug resistance DOI Open Access
James Mwangi, Hao Xue, Ren Lai

и другие.

动物学研究, Год журнала: 2019, Номер 40(6), С. 488 - 505

Опубликована: Янв. 1, 2019

The discovery of antibiotics marked a golden age in the revolution human medicine. However, decades later, bacterial infections remain global healthcare threat, and return to pre-antibiotic era seems inevitable if stringent measures are not adopted curb rapid emergence spread multidrug resistance indiscriminate use antibiotics. In hospital settings, resistant (MDR) pathogens, including carbapenem-resistant Pseudomonas aeruginosa, vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamases (ESBL) bearing Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae are amongst most problematic due paucity treatment options, increased stay, exorbitant medical costs. Antimicrobial peptides (AMPs) provide an excellent potential strategy for combating these threats. Compared empirical antibiotics, they show low tendency select resistance, killing action, broad-spectrum activity, extraordinary clinical efficacy against several MDR strains. Therefore, this review highlights among nosocomial pathogens its implications reiterates importance AMPs as next-generation superbugs.

Язык: Английский

Процитировано

237

Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs DOI Creative Commons
Natalia Molchanova, Per Brinch Hansen, Henrik Franzyk

и другие.

Molecules, Год журнала: 2017, Номер 22(9), С. 1430 - 1430

Опубликована: Авг. 29, 2017

The rapid emergence of multidrug-resistant pathogens has evolved into a global health problem as current treatment options are failing for infections caused by pan-resistant bacteria. Hence, novel antibiotics in high demand, and this reason antimicrobial peptides (AMPs) have attracted considerable interest, since they often show broad-spectrum activity, fast killing cell selectivity. However, the therapeutic potential natural AMPs is limited their short plasma half-life. Antimicrobial peptidomimetics mimic structure biological activity AMPs, but display extended stability presence matrices. In present review, focus on developments reported last decade with respect to design, synthesis, cytotoxic side effects well applications anti-infective agents. Specifically, only modular residues connected via amide linkages will be discussed. These comprise classes α-peptoids (N-alkylated glycine oligomers), β-peptoids β-alanine β3-peptides, α/β3-peptides, α-peptide/β-peptoid hybrids, α/γ N-acylated N-aminoethylpeptides (AApeptides), oligoacyllysines (OAKs). Such particular interest due potent versatile convenient optimization assembly standard solid-phase procedures.

Язык: Английский

Процитировано

228